SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-17-002234
Filing Date
2017-11-03
Accepted
2017-11-03 12:57:37
Documents
7
Period of Report
2017-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K medizone8k110217.htm 8-K 31954
2 EX-10.1 ex10-1.htm EX-10.1 125780
3 EX-10.2 ex10-2.htm EX-10.2 30996
4 EX-10.3 ex10-3.htm EX-10.3 31269
5 EX-99.1 ex99-1.htm EX-99.1 9548
6 EX-99.2 ex99-2.htm EX-99.2 11720
7 EX-99.3 ex99-3.htm EX-99.3 9748
  Complete submission text file 0001185185-17-002234.txt   252421
Mailing Address 350 EAST MICHIGAN AVENUE SUITE 500 KALAMAZOO MI 49007
Business Address 350 EAST MICHIGAN AVENUE SUITE 500 KALAMAZOO MI 49007 (269) 202-5020
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 002-93277-D | Film No.: 171175553
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries